Literature DB >> 20646240

Pneumococci: immunology of the innate host response.

Gavin K Paterson1, Carlos J Orihuela.   

Abstract

Despite the development of vaccines and antibiotics, Streptococcus pneumoniae (the pneumococcus) continues to be a major cause of human morbidity and mortality throughout the world. In recent years our understanding of how the host innate immune system recognizes and responds to pneumococcal infection has advanced significantly. Herein, we highlight some of the key features of the innate response to the pneumococcus.
© 2010 The Authors; Respirology © 2010 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646240      PMCID: PMC2956737          DOI: 10.1111/j.1440-1843.2010.01814.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  92 in total

1.  Scavenger receptors: role in innate immunity and microbial pathogenesis.

Authors:  Thomas Areschoug; Siamon Gordon
Journal:  Cell Microbiol       Date:  2009-04-22       Impact factor: 3.715

2.  TLR2 looks at lipoproteins.

Authors:  Mirjam Schenk; John T Belisle; Robert L Modlin
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

Review 3.  Molecular mechanisms involved in inflammasome activation.

Authors:  Clare Bryant; Katherine A Fitzgerald
Journal:  Trends Cell Biol       Date:  2009-08-26       Impact factor: 20.808

4.  Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.

Authors:  Catherine Hyams; Jose Yuste; Katie Bax; Emilie Camberlein; Jeffrey N Weiser; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

5.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

6.  Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice.

Authors:  Zhe Zhang; Thomas B Clarke; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

7.  Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia.

Authors:  Ernesto Hinojosa; Angela R Boyd; Carlos J Orihuela
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

Review 8.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

9.  Pneumococcal capsular polysaccharide structure predicts serotype prevalence.

Authors:  Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

Review 10.  Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

Authors:  Luke A J O'Neill; Clare E Bryant; Sarah L Doyle
Journal:  Pharmacol Rev       Date:  2009-05-27       Impact factor: 25.468

View more
  21 in total

Review 1.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

2.  Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.

Authors:  Charles S Dela Cruz; Wei Liu; Chuan Hua He; Adam Jacoby; Alex Gornitzky; Bing Ma; Richard Flavell; Chun Geun Lee; Jack A Elias
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 3.  Pneumococcal Vaccination Strategies. An Update and Perspective.

Authors:  Andrew C Berical; Drew Harris; Charles S Dela Cruz; Jennifer D Possick
Journal:  Ann Am Thorac Soc       Date:  2016-06

4.  Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.

Authors:  Valerie R Stolberg; Alexandra L McCubbrey; Christine M Freeman; Jeanette P Brown; Sean W Crudgington; Sophina H Taitano; Bridget L Saxton; Peter Mancuso; Jeffrey L Curtis
Journal:  J Immunol       Date:  2015-05-18       Impact factor: 5.422

5.  Immunosuppressive property within the Streptococcus pneumoniae cell wall that inhibits generation of T follicular helper, germinal center, and plasma cell response to a coimmunized heterologous protein.

Authors:  Swadhinya Arjunaraja; Lindsey Pujanauski; Jesus Colino; Raul M Torres; Clifford M Snapper
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

6.  Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lung.

Authors:  M Habibzay; J I Saldana; J Goulding; C M Lloyd; T Hussell
Journal:  Mucosal Immunol       Date:  2012-05-02       Impact factor: 7.313

Review 7.  Cardiotoxicity during invasive pneumococcal disease.

Authors:  Armand O Brown; Elizabeth R C Millett; Jennifer K Quint; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2015-04-01       Impact factor: 21.405

8.  The α-tocopherol form of vitamin E reverses age-associated susceptibility to streptococcus pneumoniae lung infection by modulating pulmonary neutrophil recruitment.

Authors:  Elsa N Bou Ghanem; Stacie Clark; Xiaogang Du; Dayong Wu; Andrew Camilli; John M Leong; Simin N Meydani
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

9.  Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay.

Authors:  Eliza J R Peterson; Dmitri Kireev; Andrea F Moon; Marika Midon; William P Janzen; Alfred Pingoud; Lars C Pedersen; Scott F Singleton
Journal:  J Biomol Screen       Date:  2012-09-26

10.  Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia.

Authors:  Dana C Blok; Koenraad F van der Sluijs; Sandrine Florquin; Onno J de Boer; Cornelis van 't Veer; Alex F de Vos; Tom van der Poll
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.